Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1141

L-α-glycerophosphorylcholine

Intended Use: Intended for use as a source of choline at levels up to 600 mg/serving in soft drinks, sports and energy drinks, powdered beverage mixes, coffee and tea, gummy candy, nutritional beverages, protein and nutritional powders, and cereal and nutrition bars.
Basis: Scientific procedures
Notifier: Shenyang Gold Jyouki Technology Co., Ltd
Notifier Address: Shenyang Gold Jyouki Technology Co., Ltd
Room 401, Building F8, No. 860-1
Shenben Avenue, Hunnan District,
Shenyang, Liaoning
China
GRAS Notice (releasable information): GRN 1141 with amendments (in PDF) (17.3 MB)
Date of closure: Apr 29, 2024
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (89 kB)
-
-